Solange Peters | Oncology | Research Excellence Award

Prof. Solange Peters | Oncology | Research Excellence Award

Lausanne University | Switzerland

Dr. Solange Peters is an internationally recognized medical oncologist and academic leader specializing in thoracic oncology. She serves as Director of the Oncology Department at Lausanne University Hospital and is a Full Professor at the University of Lausanne. Dr. Peters is widely known for her expertise in lung cancer, immunotherapy, and precision oncology, with a strong focus on clinical research and translational medicine. She has led and coordinated numerous international multicenter clinical trials and has contributed significantly to advancing treatment standards for thoracic malignancies. With extensive experience in medical education, she is actively involved in training oncology professionals worldwide. Dr. Peters has authored more than 500 peer-reviewed scientific publications and serves in key editorial roles for leading oncology journals. She has held prominent leadership positions in major international oncology organizations and is a strong advocate for multidisciplinary cancer care, innovation in clinical research, and the advancement of women in oncology.

Citation Metrics (Scopus)

70,000
50,000
10,000
  1000
        0

Citations
58,125

Documents
483
h-index
104

Citations

Documents

h-index


View Scopus Profile    View Oricd Profile

Featured Publications


Regulation of laboratory-developed tests and in-house in vitro diagnostic medical devices in the United States and the European Union—a comparative overview

– Review Article (Open Access)

Quality improvement report: Investigating barriers in HIV testing oncology patients to optimize HIV testing practice

– HIV Medicine

Tumor immune dynamics and long-term clinical outcome of stage IIIA NSCLC patients treated with neoadjuvant chemoimmunotherapy

– Nature Communications

Brief Report: Post Hoc Validation of Platinum Ineligibility in NSCLC From the Phase III IPSOS Study

– Journal of Thoracic Oncology

Transcriptome analysis of archived tumors by Visium, GeoMx DSP, and Chromium reveals patient heterogeneity

– Nature Communications

Yudai Shimojukkoku | Oncology | Best Researcher Award

Dr. Yudai Shimojukkoku | Oncology | Best Researcher Award

Dr. Yudai Shimojukkoku, Saitama Cancer Center, Japan.

Dr. Shimojukkoku Yudai 🧑‍🔬 is a dedicated cancer researcher at Saitama Cancer Center and Kagoshima University. His work focuses on oral squamous cell carcinoma, exploring the tumor microenvironment and identifying novel biomarkers 🧫. He collaborates with renowned experts like Prof. Sasahira, advancing both basic and clinical research. His contributions aim to bridge the gap between oral health and systemic diseases such as diabetes 🦷❤️. Dr. Yudai’s research is paving the way for innovative cancer diagnostics and treatments. 🌟

Profile

SCOPUS ID

🎓 Early Academic Pursuits

Dr. Shimojukkoku Yudai embarked on his academic journey with a deep-rooted passion for medical sciences, particularly in oncology. He demonstrated an early commitment to understanding the biological mechanisms of cancer, eventually focusing his expertise on oral squamous cell carcinoma. His educational background provided a strong foundation in both clinical and molecular pathology, setting the stage for a career centered on bridging lab-based discoveries with real-world clinical applications.

💼 Professional Endeavors

Currently affiliated with the Saitama Cancer Center and Kagoshima University’s Department of Molecular and Oral Pathology, Dr. Yudai combines research with clinical responsibilities. He is deeply involved in improving diagnostic techniques and therapeutic approaches in oral cancer. His daily work integrates patient-centered care with experimental exploration, ensuring translational relevance of his research.

🔬 Contributions and Research Focus On Oncology 

Dr. Yudai’s research targets the tumor microenvironment and identification of novel biomarkers in oral cancer. He has led and participated in both in vitro and in vivo studies, as well as computational analyses (in silico) to discover two previously unidentified markers that have since influenced ongoing investigative studies. His active collaboration with renowned cancer researcher Prof. Sasahira has further enhanced his research on the link between oral cancer and periodontal disease, and the complex relationship between cancer progression and diabetes mellitus.

🌍 Impact and Influence

Although early in his career, Dr. Yudai’s work has begun to leave a significant impact in the field of oral oncology. His insights are contributing to the evolving understanding of how systemic diseases and oral cancer interact. His research, while currently limited in citation due to its recent publication, presents promising implications for clinical diagnostics and personalized cancer therapy. His focus on translational outcomes ensures his findings are poised to improve patient outcomes in the near future.

🧠 Research Skills

Dr. Yudai demonstrates a versatile skill set encompassing molecular biologyhistopathologybioinformatics, and clinical oncology. He is adept at designing and executing comprehensive experimental workflows and data interpretation. His capacity to blend clinical insights with molecular discoveries makes him a valuable asset in precision medicine research.

🏅 Awards and Honors

Dr. Yudai is actively seeking recognition in categories such as the Young Scientist Award, Best Researcher Award, Outstanding Scientist Award, and Best Research Scholar Award. His self-motivated dedication, impactful publications, and meaningful collaborations make him a strong contender for these accolades. His contributions signify excellence in early-stage cancer research.

🏛️ Legacy and Future Contributions

As he advances, Dr. Yudai aims to pioneer new diagnostic tools and therapeutic targets that can revolutionize the treatment of oral cancers. His collaborative spirit and interdisciplinary research vision promise continued contributions to global cancer research. With a commitment to both innovation and patient care, he is laying a foundation that could influence generations of oncological practice and research.

Publications Top Notes

📘 Title: MCTP2 is a novel biomarker promoting tumor progression and nodal metastasis in oral squamous cell carcinoma
🧑‍🔬 Authors: Shimojukkoku Yudai, et al.
📚 Journal: Scientific Reports
📅 Year: 2025
🔗 Link: https://www.nature.com/articles/s41598-025-02094-9 (🔒 Currently disabled)
🧬 Highlights: Introduces MCTP2 as a promising biomarker for tumor progression and nodal metastasis in oral squamous cell carcinoma.